About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Portland | 9,757 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,757 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5321-5340 of 9,757 trials

Active not recruitingA Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)This Phase III, randomized, double-blind, placebo-controlled, multicenter study will evaluate the efficacy and safety of giredestrant combined with palbociclib compared with…NCT04546009·Fountain Valley, California and 254 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingA Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by SurgeryThis phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that has grown after at least one…NCT04195399·Birmingham, Alabama and 97 others

CompletedInvestigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1A randomized, placebo-controlled, double-blind, parallel group, multi center study to assess the safety and efficacy of tiotropium bromide (18 µg) delivered via the HandiHaler® in…NCT01663987·Birmingham, Alabama and 49 others

CompletedReduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)The objective of this study is to determine if combination therapy (reduced-fluence Visudyne followed by Lucentis \[within 2 hours\] or either of two regimens of reduced-fluence…NCT00492284·Mobile, Alabama and 25 others

TerminatedA Phase 1 Study of ADA-011 for Subjects With Advanced Solid TumorsThis study consists of dose escalation evaluation to determine the safety and tolerability of ADA-011 as a monotherapy.NCT05601219·Scottsdale, Arizona and 4 others

CompletedEvaluation of Vitrectomy for Diabetic Macular EdemaThe study is designed as a prospective cohort study to assess changes in visual acuity and retinal thickening and surgical complications in subjects undergoing vitrectomy for…NCT00709319·Irvine, California and 47 others

CompletedEfficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaThe purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with simvastatin on cholesterol levels in treating patients with elevated cholesterol.NCT00286481·Huntsville, Alabama and 66 others

CompletedRexMedical- Option* Vena Cava Filter IDE StudyThis study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary…NCT00488865·Burlingame, California and 9 others

CompletedEfficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisThis is a multicenter, randomized, double-blind, placebo-controlled, study comparing the efficacy and safety of intravenous (IV) efzofitimod 3 mg/kg and 5 mg/kg versus placebo…NCT05415137·Birmingham, Alabama and 90 others

CompletedLong-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)This study is an extension of previous rAvPAL-PEG studies.NCT00924703·Aurora, Colorado and 13 others

CompletedHealth Protection & Promotion for Oregon Correctional OfficersMore than 530,000 individuals work as US Correctional Officers (COs) responsible for overseeing the approximately 1.6 million offenders who are incarcerated at any given time in…NCT02098603·Portland, Oregon

CompletedA Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderThe purpose of this study is to compare the tolerability and efficacy of different doses of duloxetine in patients with major depressive disorder.NCT00191061·Little Rock, Arkansas and 31 others

TerminatedAn Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the USThis is a prospective, single-arm, multicenter, non-interventional study of aducanumab-avwa as prescribed in the post-marketing setting in the US.NCT05097131·Chula Vista, California and 21 others

Active not recruitingA Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin, glofitamab, or mosunetuzumab…NCT04970901·Clovis, California and 39 others

CompletedA Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisThe purpose of the study is to evaluate pharmacokinetic similarity, efficacy, safety and immunogenicity of multiple switches between ustekinumab and ABP 654 compared with…NCT04761627·Hot Springs, Arkansas and 87 others

CompletedTAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)1703: The study is designed as a randomized, phase III, multicenter trial comparing two acute graft-versus-host disease (aGVHD) prophylaxis regimens: tacrolimus/methotrexate…NCT03959241·Birmingham, Alabama and 38 others

RecruitingReduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)CASSINI-US is a prospective, single-arm, multicenter early feasibility study enrolling up to 15 patients at up to 5 sites in the United States (US).NCT07130994·Los Angeles, California and 4 others

Active not recruitingPembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast CancerThis is a Phase II, randomized, open-label trial to evaluate the clinical and immunologic activity of pembrolizumab plus chemotherapy when combined with various immunotherapy…NCT04373031·Portland, Oregon

CompletedTesting the Effects of Palbociclib and Fulvestrant or Letrozole for Patients 70 Years of Age of Older With Metastatic Breast CancerThis phase II trial studies the side effects and how well palbociclib and letrozole or fulvestrant works in treating patients aged 70 years and older with estrogen receptor…NCT03633331·Anchorage, Alaska and 446 others

Active not recruitingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesThis is a first-in-human open-label Phase 1/2a study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of 23ME-00610…NCT05199272·Palo Alto, California and 12 others

PreviousPage 267 of 488Next

in Portland

Heart Diseasein Portland